Microneedle Drug Delivery CRO/CDMO
Hours: 8:30 AM–5:30 PMSales: +86 10 8928 7035Business: bd@casmn.com

MICRONEEDLE DEVELOPMENT CAPABILITY

Microneedle Feasibility Assessment

Determine whether your payload, target dose and product requirements can support a practical microneedle development pathway.

Feasibility Assessment Framework

Illustrative assessment framework. The relative importance of each dimension varies by project.
01

Why Feasibility Comes First

Early feasibility establishes whether a practical microneedle product pathway should be pursued before larger formulation and process investment.

02

Key Questions We Need to Answer

The assessment focuses on the technical decisions that determine whether development can proceed.

  • Can the target dose fit the product concept?
  • Is the payload compatible with the formulation and process?
  • Which microneedle class is suitable?
  • What delivery performance is required?
  • Are there major scale-up risks?
03

Information Needed for Assessment

Non-confidential payload information, target dose, intended use, available stability data, target product profile, development stage, market and timeline support a useful assessment.

04

Assessment Activities

Activities may include payload and dose review, initial compatibility assessment, technology-pathway selection, prototype-scope definition and early manufacturability review.

05

Decision and Output

The outcome may be a go decision, a revised concept, an alternative technology recommendation or a request for additional data before proceeding.

Technical Review — Reviewed by: CASMN R&D Team · Last reviewed: August 2026.

Discuss This Capability

Send your target product, payload, development stage and cooperation scope to our business development team.

Start a Project